We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$77.4B
AUM Growth
-$741M
(-0.95%)
Cap. Flow
-$676M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,421
New
35
Increased
882
Reduced
429
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$347M |
| 2 |
RTX Corp
RTX
|
+$322M |
| 3 |
Synopsys
SNPS
|
+$228M |
| 4 |
Cadence Design Systems
CDNS
|
+$227M |
| 5 |
Manhattan Associates
MANH
|
+$222M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$383M |
| 2 |
Broadcom
AVGO
|
+$320M |
| 3 |
Gilead Sciences
GILD
|
+$281M |
| 4 |
Newmont
NEM
|
+$261M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.99% |
| 2 | Materials | 26.22% |
| 3 | Healthcare | 8.42% |
| 4 | Industrials | 7.31% |
| 5 | Financials | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Agilent Technologies
A
$39.1B
| $373M | 0.48% |
3,192,693
-42,570
| -1% | -$5.74M |
|
52
GE HealthCare
GEHC
$30.7B
| $369M | 0.48% |
4,567,774
-273,878
| -6% | -$23.5M |
|
53
Huntington Ingalls Industries
HII
$12.9B
| $363M | 0.47% |
1,777,365
+350,668
| +25% | +$66.5M |
|
54
Walt Disney
DIS
$167B
| $359M | 0.46% |
3,632,231
-503,382
| -12% | -$54.1M |
|
55
Danaher
DHR
$137B
| $356M | 0.46% |
1,736,670
+806,802
| +87% | +$176M |
|
56
Adobe
ADBE
$99.5B
| $348M | 0.45% |
906,106
+36,758
| +4% | +$15.8M |
|
57
Estee Lauder
EL
$30.4B
| $343M | 0.44% |
5,193,048
+196,644
| +4% | +$14.2M |
|
58
Nike
NKE
$61.9B
| $336M | 0.43% |
5,295,991
-207,850
| -4% | -$15.3M |
|
59
Constellation Brands
STZ
$22.2B
| $336M | 0.43% |
1,829,855
+905,581
| +98% | +$165M |
|
60
United Parcel Service
UPS
$88.6B
| $334M | 0.43% |
3,041,068
-109,833
| -3% | -$13.1M |
|
61
West Pharmaceutical
WST
$24B
| $324M | 0.42% |
1,447,848
+758,355
| +110% | +$209M |
|
62
Fortinet
FTNT
$119B
| $321M | 0.41% |
3,267,319
-209
| -0% | -$21.2K |
|
63
Tyler Technologies
TYL
$12.7B
| $320M | 0.41% |
550,299
-281
| -0.1% | -$167K |
|
64
OR Royalties Inc
OR
$5.58B
| $314M | 0.41% |
14,867,494
-1,986,947
| -12% | -$38.2M |
|
65
Compañía de Minas Buenaventura
BVN
$7.69B
| $314M | 0.41% |
20,078,855
-1,265,467
| -6% | -$17M |
|
66
C.H. Robinson
CHRW
$17.4B
| $308M | 0.4% |
3,007,792
+218
| +0% | +$22K |
|
|
67
Bristol-Myers Squibb
BMY
$133B
| $305M | 0.39% |
4,993,118
-4,076,708
| -45% | -$238M |
|
68
Lam Research
LRCX
$367B
| $299M | 0.39% |
4,115,920
-384,221
| -9% | -$30.3M |
|
69
Amgen
AMGN
$208B
| $297M | 0.38% |
952,856
-85,737
| -8% | -$25.3M |
|
70
Ares Capital
ARCC
$13.5B
| $287M | 0.37% |
12,943,060
-1,202,646
| -9% | -$27.3M |
|
71
Leidos
LDOS
$14.5B
| $285M | 0.37% |
2,110,438
+1,268,959
| +151% | +$177M |
|
72
Merck
MRK
$322B
| $278M | 0.36% |
3,091,846
-57,995
| -2% | -$5.41M |
|
73
IAMGOLD
IAG
$8.2B
| $276M | 0.36% |
44,103,726
-5,748,200
| -12% | -$34M |
|
74
Coeur Mining
CDE
$15.4B
| $275M | 0.36% |
46,407,617
+14,664,037
| +46% | +$90.5M |
|
75
SLB Ltd
SLB
$73.6B
| $262M | 0.34% |
6,270,706
-1,833,009
| -23% | -$75.1M |
|
Similar funds
VanEck Associates's Q1 2025 Portfolio in Review
As of Q1 2025, VanEck Associates held 1,421 positions worth $77.4B, down 0.95% from $78.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4.5%. VanEck Associates opened 35 new positions and exited 29, leaving the 1,421-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 41% a quarter earlier, followed by Materials and Healthcare.
- VanEck Associates's largest Q1 2025 buy was Philip Morris: 2,449,251 shares worth $389M.
- VanEck Associates added most to RTX Corp in Q1 2025, an estimated $322M increase.
- VanEck Associates's biggest Q1 2025 reduction was TSMC, cutting an estimated $383M.
- VanEck Associates fully exited Celestica in Q1 2025, selling an estimated $9.19M.
- VanEck Associates's ten largest holdings make up 26% of its $77.4B portfolio in Q1 2025.
- VanEck Associates opened 35 new positions and closed 29 in Q1 2025.
- VanEck Associates's portfolio value fell 0.95% quarter-over-quarter to $77.4B.
Based on VanEck Associates's 13F filing for Q1 2025, filed 15 May 2025.